Myovant Sciences Debt to Equity Ratio 2017-2022 | MYOV
Current and historical debt to equity ratio values for Myovant Sciences (MYOV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Myovant Sciences debt/equity for the three months ending December 31, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-12-31 | $0.96B | $-0.56B | -1.72 |
| 2022-09-30 | $1.00B | $-0.51B | -1.94 |
| 2022-06-30 | $0.94B | $-0.48B | -1.95 |
| 2022-03-31 | $0.99B | $-0.47B | -2.10 |
| 2021-12-31 | $1.04B | $-0.43B | -2.40 |
| 2021-09-30 | $1.06B | $-0.38B | -2.78 |
| 2021-06-30 | $1.13B | $-0.40B | -2.82 |
| 2021-03-31 | $1.08B | $-0.35B | -3.05 |
| 2020-12-31 | $1.05B | $-0.27B | -3.86 |
| 2020-09-30 | $0.34B | $-0.20B | -1.68 |
| 2020-06-30 | $0.26B | $-0.14B | -1.94 |
| 2020-03-31 | $0.21B | $-0.11B | -1.98 |
| 2019-12-31 | $0.18B | $-0.05B | -3.65 |
| 2019-09-30 | $0.17B | $0.02B | 9.66 |
| 2019-06-30 | $0.17B | $0.08B | 2.15 |
| 2019-03-31 | $0.17B | $0.00B | 38.91 |
| 2018-12-31 | $0.16B | $0.05B | 3.32 |
| 2018-09-30 | $0.09B | $0.07B | 1.27 |
| 2018-06-30 | $0.09B | $0.06B | 1.57 |
| 2018-03-31 | $0.08B | $0.04B | 2.16 |
| 2017-12-31 | $0.06B | $0.08B | 0.68 |
| 2017-09-30 | $0.02B | $0.12B | 0.15 |
| 2017-06-30 | $0.02B | $0.15B | 0.12 |
| 2017-03-31 | $0.02B | $0.17B | 0.11 |
| 2016-12-31 | $0.01B | $0.19B | 0.04 |
| 2016-09-30 | $0.04B | $-0.04B | -1.05 |
| 2016-06-30 | $0.01B | $-0.01B | -1.06 |
